Literature DB >> 26847955

Insights into epidemiology of human parvovirus B19 and detection of an unusual genotype 2 variant, Bulgaria, 2004 to 2013.

Stefka Krumova Ivanova1, Zafira Georgieva Mihneva, Andon Krumov Toshev, Valentina Pavlova Kovaleva, Lubena Georgieva Andonova, Claude P Muller, Judith M Hübschen.   

Abstract

The present study aimed to determine the role of human parvovirus В19 (B19V) as an aetiological agent in measles and rubella negative fever/rash patients from Bulgaria between 2004 and 2013. A total of 1,266 sera from all over the country were tested for B19V IgM antibodies and all positives were further investigated by polymerase chain reaction (PCR). Overall, 280 sera (22%) were B19V IgM positive and 227 of these (81%) were also PCR positive. The highest number of IgM positives was found among five to nine year-old children (27%). Eight infected women gave birth to healthy children; one fetus was aborted with hydrops fetalis. Of the 55 genetic sequences obtained, 54 belonged to genotype 1a and one grouped as a genotype 2 outlier. Phylogenetic analysis of all available genotype 2 sequences covering the 994 nucleotide non-structural protein 1(NS1)/capsid viral protein 1 (VP1) unique region junction, showed that only one other sequence grouped with the outlier strain, forming a clearly distinct and well-supported cluster of genotype 2 (between-group genetic distance: 3.32%). In accordance with B19V nomenclature, this cluster may represent a new subgenotype 2b. The study showed that B19V infections may be falsely identified as rubella or measles in ca 22% of cases, emphasising the need for laboratory confirmation.

Entities:  

Keywords:  ELISA; IgM antibodies; PCR; genotype; human parvovirus B19

Mesh:

Substances:

Year:  2016        PMID: 26847955     DOI: 10.2807/1560-7917.ES.2016.21.4.30116

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  6 in total

1.  Comprehensive surveillance data suggest a prominent role of parvovirus B19 infection in Belarus and the presence of a third subtype within subgenotype 1a.

Authors:  Marina A Yermalovich; Alina M Dronina; Galina V Semeiko; Elena O Samoilovich; Vladislav V Khrustalev; Aurelie Sausy; Judith M Hübschen
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Primate Erythroparvovirus 1 Infection in Patients with Hematological Disorders.

Authors:  Stefka Krumova; Ivona Andonova; Radostina Stefanova; Polina Miteva; Galina Nenkova; Judith M Hübschen
Journal:  Pathogens       Date:  2022-04-21

4.  Molecular screening of the human parvoviruses B19 and bocavirus 1 in the study of congenital diseases as applied to symptomatic pregnant women and children.

Authors:  Maria Belen Salbetti; Mauro Sebastian Pedranti; Paula Barbero; Paula Molisani; Martina Lazzari; Nicolas Olivera; Maria Beatriz Isa; Ariel Bertoldi; Laura Moreno; Maria Pilar Adamo
Journal:  Access Microbiol       Date:  2019-06-20

5.  Prevalence and Genotypes of Parvovirus B19 Among HIV Positive Children in Ibadan, Oyo State, Nigeria.

Authors:  B O Aleru; B A Olusola; A O Faneye; G N Odaibo; D O Olaleye
Journal:  Arch Basic Appl Med       Date:  2018-05-05

6.  Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.

Authors:  Doua Abdelrahman; Duaa W Al-Sadeq; Maria K Smatti; Sara A Taleb; Raed O AbuOdeh; Enas S Al-Absi; Asmaa A Al-Thani; Peter V Coyle; Nader Al-Dewik; Ahmed A Al Qahtani; Hadi M Yassine; Gheyath K Nasrallah
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.